Pierre Fabre Pharmaceuticals seeks an FDA path forward for tabelecleucel in EBV-positive PTLD after a Complete Response Letter. Discover what regulators may scrutinize next.
DarioHealth targets oral GLP-1 therapy support with behavioral digital tools. Discover how digital health platforms could reshape obesity and diabetes treatment.
FDA grants rare hearing to review Vanda Pharmaceuticals’ HETLIOZ jet lag application. Discover what this regulatory fight could mean for circadian medicine.
Pillar Biosciences launches rapid AML sequencing panel as Creatv Bio liquid biopsy enters colorectal cancer trial. Explore what these tools mean for oncology research.
Creatv Bio’s LifeTracDx joins CytoDyn’s Phase 2 colorectal cancer trial as a liquid biopsy biomarker tool. Discover what this means for oncology diagnostics.
Insilico Medicine and Liquid AI unveil a lightweight AI model for drug discovery. Learn how smaller foundation models could reshape pharmaceutical research.
Adela’s methylome blood test may help detect immunotherapy response earlier in cancer care. Discover what the latest study reveals for clinicians and diagnostics markets.
France approves reimbursement for MR-guided focused ultrasound in essential tremor. Discover what the policy change means for neurosurgery and patient access.
Genentech's obinutuzumab met all ALLEGORY phase III endpoints in SLE. What the remission and flare data mean for lupus treatment strategy.
FDA grants De Novo clearance to LifeVac as the first authorized anti choking device. Discover what this means for emergency airway care and medical device regulation.